Actinium Pharmaceuticals (STU:7AY1) Accounts Payable & Accrued Expense : €6.03 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Actinium Pharmaceuticals Accounts Payable & Accrued Expense?

Actinium Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2024 (€6.48 Mil) to Dec. 2024 (€7.23 Mil) but then declined from Dec. 2024 (€7.23 Mil) to Mar. 2025 (€6.03 Mil).

Actinium Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2022 (€9.56 Mil) to Dec. 2023 (€7.29 Mil) and declined from Dec. 2023 (€7.29 Mil) to Dec. 2024 (€7.23 Mil).

Actinium Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Actinium Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinium Pharmaceuticals Accounts Payable & Accrued Expense Chart

Actinium Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.57

4.90

9.56

7.29

7.23

Actinium Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6.91	8.53	6.48	7.23	6.03

Actinium Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Actinium Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinium Pharmaceuticals Inc (STU:7AY1) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ATNM:USA 7AY1:Germany

Address

100 Park Avenue, 23rd Floor, New York, NY, USA, 10017

Website

https://www.actiniumpharma.com

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Actinium Pharmaceuticals Headlines

No Headlines